|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.2 EUR | 0.00% |
|
-0.89% | -1.33% |
| Apr. 18 | PharmaSGP Holding SE Proposes Dividend for the Financial Year 2023 | CI |
| Apr. 18 | PharmaSGP Holding SE Announces Changes to Dividend Policy | CI |
PharmaSGP Holding SE reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was EUR 75.68 million compared to EUR 63.95 million a year ago. Net income was EUR 11.65 million compared to EUR 8.61 million a year ago.
Basic earnings per share from continuing operations was EUR 0.97 compared to EUR 0.72 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -1.33% | 284M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
PHARMASGP HOLDING SE 
